and 8, 2004, in Washington, DC. There were four panels that considered the following topics: the science of genomics, bridging genomics and public health, and gene–environment interactions; clinical use of genomic information, cost-effectiveness analysis, genomic information and behavior, and effecting population change; the public health system, international lessons, educating the public, and capacity; and data, financing and access, and legal and regulatory issues (see Appendix C for the workshop agenda).

This report summarizes the workshop presentations and commentary. It is important to note that, with the exception of the section entitled “Priorities,” all material is taken directly from the workshop presentations. No additional material has been added, nor have analyses or interpretations of the presentations been made. As described in the charge to the committee, the “Priorities” section of the report does contain committee conclusions regarding prioritization of issues raised by the presenters with suggestions for next steps.